CHINA PHARMA HOLDINGS, INC. Increase (Decrease) in Prepaid Supplies
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Increase (Decrease) in Prepaid Supplies of -$4.71 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidSupplies · last filed 2026-08-14
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in prepaid supplies for the quarter ending 2026-06-30 was -$2.16K.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in prepaid supplies for the quarter ending 2026-03-31 was -$2.55K.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in prepaid supplies for the quarter ending 2025-12-31 was -$17.01K, a 215.38% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in prepaid supplies for the quarter ending 2025-09-30 was $18.70K, a 9248.50% increase year-over-year.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in prepaid supplies for fiscal 2025 was -$8.33K, a 163.62% decline from fiscal 2024.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in prepaid supplies for fiscal 2024 was $13.10K.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in prepaid supplies for fiscal 2023 was -$437.43K, a 195.10% decline from fiscal 2022.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in prepaid supplies for fiscal 2022 was $459.96K.
| Period end | Increase (Decrease) in Prepaid Supplies 3 month | Increase (Decrease) in Prepaid Supplies 6 month | Increase (Decrease) in Prepaid Supplies 9 month | Increase (Decrease) in Prepaid Supplies 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$2.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$4.71K 10-Q · filed 2026-08-14 | -$21.72K derived: sum of 3 quarters · filed 2026-08-14 | -$3.02K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$2.55K 10-Q · filed 2026-05-15 | -$19.56K derived: sum of 2 quarters · filed 2026-05-15 | -$860.00 derived: sum of 3 quarters · filed 2026-05-15 | -$4.75K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$17.01K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $1.69K derived: sum of 2 quarters · filed 2026-04-01 | -$2.20K derived: sum of 3 quarters · filed 2026-08-14 | -$8.33K 10-K · filed 2026-04-01 |
| 2025-09-30 | $18.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $14.81K derived: sum of 2 quarters · filed 2026-08-14 | $8.68K 10-Q · filed 2025-11-12 | $23.42K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$3.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$10.02K 10-Q · filed 2026-08-14 | $4.72K derived: sum of 3 quarters · filed 2026-08-14 | $4.92K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$6.13K 10-Q · filed 2026-05-15 | $8.61K derived: sum of 2 quarters · filed 2026-05-15 | $8.81K derived: sum of 3 quarters · filed 2026-05-15 | -$2.35K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $14.74K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $14.94K derived: sum of 2 quarters · filed 2026-04-01 | $3.78K derived: sum of 3 quarters · filed 2026-04-01 | $13.10K 10-K · filed 2026-04-01 |
| 2024-09-30 | $200.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$10.96K derived: sum of 2 quarters · filed 2025-11-12 | -$1.65K 10-Q · filed 2025-11-12 | -$2.49K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$11.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$1.84K 10-Q · filed 2025-08-14 | -$2.69K derived: sum of 3 quarters · filed 2025-08-14 | -$144.65K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $9.32K 10-Q · filed 2025-05-14 | $8.47K derived: sum of 2 quarters · filed 2025-05-14 | -$133.49K derived: sum of 3 quarters · filed 2025-05-14 | |
| 2023-12-31 | -$849.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$142.81K derived: sum of 2 quarters · filed 2025-03-31 | -$437.43K 10-K · filed 2025-03-31 | |
| 2023-09-30 | -$141.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$436.58K 10-Q · filed 2024-11-13 | ||
| 2023-06-30 | -$294.63K 10-Q · filed 2024-08-14 | |||
| 2022-12-31 | $451.56K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $459.96K 10-K · filed 2024-04-01 | ||
| 2022-09-30 | $8.39K 10-Q · filed 2023-11-13 | |||
| 2020-03-31 | $1.07M 10-Q · filed 2020-05-14 | $1.06M derived: sum of 2 quarters · filed 2020-05-14 | $1.06M derived: sum of 3 quarters · filed 2020-05-14 | $958.16K derived: sum of 4 quarters · filed 2020-05-14 |
| 2019-12-31 | -$2.62K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$10.25K derived: sum of 2 quarters · filed 2020-03-30 | -$107.48K derived: sum of 3 quarters · filed 2020-03-30 | $361.00 10-K · filed 2020-03-30 |
| 2019-09-30 | -$7.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$104.86K derived: sum of 2 quarters · filed 2019-11-14 | $2.98K 10-Q · filed 2019-11-14 | $559.06K derived: sum of 4 quarters · filed 2020-05-14 |
| 2019-06-30 | -$97.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $10.62K 10-Q · filed 2019-08-14 | $566.70K derived: sum of 3 quarters · filed 2020-05-14 | $573.24K derived: sum of 4 quarters · filed 2020-05-14 |
| 2019-03-31 | $107.84K 10-Q · filed 2020-05-14 | $663.92K derived: sum of 2 quarters · filed 2020-05-14 | $670.46K derived: sum of 3 quarters · filed 2020-05-14 | $319.77K derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $556.08K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $562.62K derived: sum of 2 quarters · filed 2020-03-30 | $211.94K derived: sum of 3 quarters · filed 2020-03-30 | $449.10K 10-K · filed 2020-03-30 |
| 2018-09-30 | $6.54K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$344.15K derived: sum of 2 quarters · filed 2019-11-14 | -$106.98K 10-Q · filed 2019-11-14 | -$1.97M derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | -$350.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$113.52K 10-Q · filed 2019-08-14 | -$1.98M derived: sum of 3 quarters · filed 2019-08-14 | -$1.74M derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | $237.16K 10-Q · filed 2019-05-14 | -$1.63M derived: sum of 2 quarters · filed 2019-05-14 | -$1.39M derived: sum of 3 quarters · filed 2019-05-14 | -$1.40M derived: sum of 4 quarters · filed 2019-05-14 |
| 2017-12-31 | -$1.87M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-28 | -$1.62M derived: sum of 2 quarters · filed 2019-03-28 | -$1.63M derived: sum of 3 quarters · filed 2019-03-28 | -$1.61M 10-K · filed 2019-03-28 |
| 2017-09-30 | $241.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $233.80K derived: sum of 2 quarters · filed 2018-11-14 | $251.31K 10-Q · filed 2018-11-14 | -$280.08K derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | -$7.58K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $9.93K 10-Q · filed 2018-08-14 | -$521.45K derived: sum of 3 quarters · filed 2018-08-14 | -$665.60K derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | $17.51K 10-Q · filed 2018-05-14 | -$513.88K derived: sum of 2 quarters · filed 2018-05-14 | -$658.02K derived: sum of 3 quarters · filed 2018-05-14 | |
| 2016-12-31 | -$531.38K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -$675.53K derived: sum of 2 quarters · filed 2018-04-02 | -$380.78K 10-K · filed 2018-04-02 | |
| 2016-09-30 | -$144.15K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $150.61K 10-Q · filed 2017-11-14 | ||
| 2016-06-30 | $294.75K 10-Q · filed 2017-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |